Effect of association of temozolomide with other chemotherapic agents on cell growth inhibition in glioma cell lines

Oncology Research

Volumn 14, Issue 7-8, 2004, Pages 325-330

  Balzarotti, Marco ^a   Ciusani, Emilio ^a   Calatozzolo, Chiara ^a   Croci, Danilo ^a   Boiardi, Amerigo ^a   Salmaggi, Andrea ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Cis platinum; Doxorubicin; Glioma; Locoregional; Temozolomide; Topotecan

Indexed keywords

ANTINEOPLASTIC AGENT; CAELIX; CISPLATIN; DOXORUBICIN; NITROSOUREA; TEMOZOLOMIDE; TOPOTECAN;

ARTICLE; CANCER INHIBITION; CELL GROWTH; DRUG MECHANISM; DRUG POTENTIATION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 4043169888     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/0965040041292341     Document Type: Article

References (28)

1. Stewart, L. A. Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359:1011-1018; 2002.
2. Levin, V. A.; Leibel, S. A.; Gutin, P. H. Neoplasms of the central nervous system. In: De Vita, V. T.; Hellman, S.; Rosenberg, S. A., eds. Cancer: Principles and practice of oncology, 5th ed. Philadelphia: Lippincott-Raven Publishers; 1997:2022-2082.
3. Huncharck, M.; Muscat, J. Treatment of recurrent high grade astrocytoma: Results of a systematic review of 1415 patients. Anticancer Res. 18:1303-1311; 1998.
4. Gaya, A.; Rees, J.; Greenstein, A.; Stebbing, J. The use of temozolomide in recurrent malignant gliomas. Cancer Treat. Rev. 28:115-120; 2002.
5. 6alkyl-guanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J. Clin. Oncol. 16:3851-3857; 1998.
6. Yung, W. K. A.; Albright, R. E.; Olson, J.; Fredericks, R.; Fink, K.; Prados. M. D.; Brada, M.; Spence, A.; Hohl, R. J.; Shapiro, W.; Glantz, M.; Greenberg, H.; Selker, R. G.; Vick, N. A.; Rampling, R.; Friedman, H.; Phillips, P.; Bruner, J.; Yue, N.; Osoba, D.; Zaknoen, S.; Levin, V. A. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br. J. Cancer 83:588-593; 2000.
7. Boiardi, A.; Salmaggi, A.; Pozzi, A.; Broggi, G.; Silvani, A. Interstitial chemotherapy with mitoxantrone in recurrent malignant glioma: Preliminary data. J. Neurooncol. 27:157-162; 1996.
8. Kueng, W.; Silber, E.; Eppenberger, U. Quantification of cells cultured on 96-well plates. Anal. Biochem. 182:16-19; 1989
9. Chou, T. C.; Talalay, P. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22:27-55; 1984
10. Weller, M.; Rieger, J.; Grimmel, C.; Van Meir, E. G.; De Tribolet, N.; Krajewski, S.; Reed, J. C.; Von Deimling, A.; Dichgans, J. Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analyses. Int. J. Cancer 79:640-644; 1998.
11. Naumann. U.; Weller, M. Retroviral BAX gene transfer fails to sensitize malignant glioma cells to CD95L-induced apoptosis and cancer chemotherapy. Int. J. Cancer 77:645-648; 1998.
12. Bocangel, D. B.; Finkelstein, S.; Schold, S. C.; Bhakat, K. K.; Mitra, S.; Kokkinakis, D. M. Multifaceted resistance of gliomas to temozolomide. Clin. Cancer Res. 8: 2725-2734; 2002.
13. Dorigo, O.; Turla, S. T.; Lebedeva, S.; Gjerset, R. A. Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration of wild-type p53 function. J. Neurosurg. 88:535-540; 1998.
14. Schmidt, F.; Rieger, J.; Wischhusen, J.; Naumann, U.; Weller, M. Glioma cell sensitivity to topotecan: The role of p53 and topotecan-induced DNA damage. Eur. J. Pharmacol. 412:21-25; 2001.
15. Stan, A. C.; Casares, S.; Radu, D.; Walter, G. F.; Brumeanu, T. D. Doxorubicin-induced cell death in highly invasive human gliomas. Anticancer Res. 19:941-950; 1999.
16. Ma, J.; Murphy, M.; O'Dwyer, P. J.; Berman, E.; Reed, K.; Gallo, J. M. Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance. Biochem. Pharmacol. 63:1219-1228; 2002.
17. Voulgaris, S.; Partheni, M.; Karamouzis, M.; Dimopoulos, P.; Papadakis, N.; Kalofonos, H. P. Intratumoral doxorubicin in patients with malignant brain gliomas. Am. J. Clin. Oncol. 25:60-64; 2002.
18. Boiardi, A.; Eoli, M.; Salmaggi, A.; Lamperti, F.; Botturi, A.; Broggi, G.; Milanesi, I.; Silvani, A. Local delivery of chemotherapy might improve survival in recurrent glioblastoma patients. VIII Congresso-Corso residenziale della Associazione Italiana di Neuro-oncologia, Ancona 2-4/10/03.
19. Gullbo, J.; Arsenau, D.; Grundmark. B.; Alvfors, C.; Larsson, R.; Lindhagen, E. Cytotoxic activity of a new lipid formulation of doxorubicin in cell lines and primary tumor cells. Anticancer Res. 22:4191-4198; 2002.
20. von Bossanyi, P.; Diete, S.; Dietzmann, K.; Warich-Kirches, M.; Kirches. E. Immunohistochemical expression of P-glycoprotein and glutathione S-transferases in cerebral gliomas and response to chemotherapy. Acta Neuropathol. (Berl.) 94:605-611; 1997.
21. Grabenbauer, G. G.; Anders, K.; Fietkau, R. J.; Klautke, G.; Feldmann, H. J.; Weiser, S.; Staab, H. J.; Krauseneck, P.; Sauer, R. Prolonged infusional topotecan and accelerated hyperfractionated 3d-conformal radiation in patients with newly diagnosed glioblastoma-a phase I study. J. Neurooncol. 60:269-275; 2002.
22. Lamond, J. P.; Mehta, M. P.; Boothmam, D. A. The potential of topoisomerase I inhibitors in treatment of CNS malignancies: Report of a synergistic effect between topotecan and radiation. J. Neurooncol. 30:1-6; 1996.
23. Chastagner, P.; Kozin, S. V.; Taghian. A. Topotecan selectively enhances the radioresponse of human small-cell lung carcinoma and glioblastoma multiforme xenografts in nude mice. Int. J. Radiat. Oncol. Biol. Phys. 50:777-782; 2001.
24. Kaiser, M. G.; Parsa, A. T.; Fine, R. L.; Hall, J. S.; Chakrabarti, I.; Bruce, J. N. Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model. Neurosurgery 47:1391-1399; 2000.
25. Fisher, B.; Won, M.; Macdonald, D.; Johnson, D. W.; Roa, W. Phase II study of topotecan plus cranial radiation for glioblastoma multiforme: Results of Radiation Therapy Oncology Group 9513. Int. J. Radiat. Oncol. Biol. Phys. 53:980-986; 2002.
26. Bouvier, G.; Penn, R. D.; Kroin, J. S.; Beique, R.; Guerard, M. J. Direct delivery of medication into a brain tumor through multiple chronically implanted catheters. Neurosurgery 20:286-291; 1987.
27. Eoli, M.; Fariselli, L.; Salmaggi, A.; Botturi, A.; Boiardi, A.; Silvani, A. Local chemotherapy with cis-platinum concomitant to radiotherapy and systemic chemotherapy in glioblastoma. VIII Congresso-Corso residenziale della Associazione Italiana di Neuro-oncologia. Ancona 2-4/10/03.
28. Gomez-Manzano, C.; Fueyo, J.; Kyritsis, A. P.; Steck, P. A.; Roth, J. A.; McDonnell, T. J.; Steck, K. D.; Levin, V. A.; Yung, W. K. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res. 56:694-699; 1996.